Cite
HARVARD Citation
Gengenbacher, M. et al. (2008). Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. Annals of the rheumatic diseases. 67 (5), pp. 620-624. [Online].